ACOD1 and neoplasm: A study has shown that itaconate was one of the most strongly elevated metabolites in the peritoneal RTMs in peritoneal tumors, including B16 melanoma or ID8 ovarian carcinoma, and itaconate exhibited a pro-tumor effect, as proven by the dramatically decreased peritoneal tumors after Irg1 knockdown [113].